Bone Cell Bioenergetics and Skeletal Energy Homeostasis
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The rising incidence of metabolic diseases worldwide has prompted renewed interest in the study of intermediary metabolism and cellular bioenergetics. The application of modern biochemical methods for quantitating fuel substrate metabolism with advanced mouse genetic approaches has greatly increased understanding of the mechanisms that integrate energy metabolism in the whole organism. Examination of the intermediary metabolism of skeletal cells has been sparked by a series of unanticipated observations in genetically modified mice that suggest the existence of novel endocrine pathways through which bone cells communicate their energy status to other centers of metabolic control. The recognition of this expanded role of the skeleton has in turn led to new lines of inquiry directed at defining the fuel requirements and bioenergetic properties of bone cells. This article provides a comprehensive review of historical and contemporary studies on the metabolic properties of bone cells and the mechanisms that control energy substrate utilization and bioenergetics. Special attention is devoted to identifying gaps in our current understanding of this new area of skeletal biology that will require additional research to better define the physiological significance of skeletal cell bioenergetics in human health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243 · cited 1×
“Leptin, a 16-kDa peptide hormone produced by adipocytes and encoded by the Lep gene in mice (372), is a primary regulator of appetite and reproductive function (42, 129, 358).”
BackgroundCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“The IGF1R and IR lead to the activation of phosphatidylinositol 3-kinase and mitogen-activated protein kinase signaling by phosphorylating insulin receptor substrate (IRS) proteins (331), which are important for skeletal homeostasis (5, 76, 147, 253).”
BackgroundSarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Endocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 1×
“tion(s) of the osteocyte has not yet been established, most evidence supports a role as a sensory cell, which transduces mechanical queues into anabolic signals (29).”
BackgroundHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 1×
“The systemic hormones insulin and leptin exert their metabolic actions in part through AMPK (236).”
BackgroundCellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735 · cited 2×
“Subsequent studies from the Karsenty group showed that the anti-osteogenic effects of leptin were separate from the anorexigenic effects of the hormone (88, 329) and that leptin influences bone metabolism via the sympathetic nervous system, which acts on 2-adrenergic receptors expressed by osteoblasts.”
BackgroundAMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638
Body mass index as a predictor of fracture risk: A meta-analysis
De Laet, C., Kanis, J. A., Odén, A., Johanson, H., Johnell, O., Delmas, P., Eisman, J. A., Kroger, H., Fujiwara, S., Garnero, P., et al. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1863-y · Cited by 1,622
Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G., & Morrison, S. J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.06.008 · Cited by 1,381 · cited 1×
“Likewise, recent studies using lineage-tracing methods have showed that Lepr marks a marrow stromal cell whose descendants differentiate into osteoblasts that populate postnatal bone (375).”
Result(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335 · cited 1×
“In many cells, HIF-1 serves as a molecular switch diverting energy production from oxidative to glycolytic metabolism under hypoxic conditions (263, 311).”
BackgroundLeptin regulation of bone resorption by the sympathetic nervous system and CART
Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., et al. (2005) · Nature · doi:10.1038/nature03398 · Cited by 1,311 · cited 1×
“In subsequent studies, hypothalamic leptin signaling was shown to govern both arms of the bone remodeling process via sympathetic control of Atf4-mediated expression of RANKL and clock gene-mediated regulation of osteoblast proliferation (86, 107).”
BackgroundMammalian sirtuins—emerging roles in physiology, aging, and calorie restriction
Haigis, M. C., & Guarente, L. P. (2006) · Genes & Development · doi:10.1101/gad.1467506 · Cited by 1,295 · cited 1×
“Sirt3 is a member of the silent information regulator (Sir) protein family of NAD-dependent deacetylases that were initially discovered as key factors that connect metabolism with longevity in yeast, worms, and flies (128).”
BackgroundThe TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 1×
“Raptor associates with the TORC1 complex to control protein synthesis, ribosome biogenesis, and nutrient transport (133), whereas Rictor is a component of the TORC2 complex that regulates cell survival, metabolism, and cytoskeletal organization (150, 300).”
BackgroundPajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311113200 · Cited by 1,163
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
Ferron, M., Wei, J., Yoshizawa, T., Del Fattore, A., DePinho, R. A., Teti, A., Ducy, P., & Karsenty, G. (2010) · Cell · doi:10.1016/j.cell.2010.06.003 · Cited by 1,123 · cited 5×
“in the Karsenty laboratory (101) led to the conclusion that osteocalcin production and bioavailability are under the control of insulin.”
BackgroundResultInfluentialMechanisms of diabetes mellitus-induced bone fragility
On behalf of the IOF Bone and Diabetes Working Group, Napoli, N., Chandran, M., Pierroz, D. D., Abrahamsen, B., Schwartz, A. V., & Ferrari, S. L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.153 · Cited by 1,107 · cited 1×
“The mechanisms by which alterations in glucose homeostasis affect bone mass and strength are quite complex and can include alterations in matrix deposition, glucotoxicity in bone cells, and the modification of collagen by advance glycation end products (170, 176, 244).”
BackgroundSkeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069 · cited 1×
“The bone remodeling cycle (FIGURE 1) is initiated by osteoclasts, multinucleated polykaryons that differentiate from hematopoietic stem cells under the control of the receptor activator of nuclear factor kappa-B ligand (RANKL) signaling (370).”
BackgroundThe Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Pathogenesis of bone fragility in women and men
Seeman, E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08706-8 · Cited by 909
Recombinant human leptin in women with hypothalamic amenorrhea
Welt, C. K., Chan, J. L., Bullen, J., Murphy, R., Smith, P., DePaoli, A. M., Karalis, A., & Mantzoros, C. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040388 · Cited by 908
Ferron, M., Hinoi, E., Karsenty, G., & Ducy, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711119105 · Cited by 900 · cited 1×
“Ferron and colleagues (98, 100) continued the Karsenty laboratory’s analysis of the metabolic functions of osteocalcin by assessing its potential therapeutic use when delivered via osmotic mini-pumps or daily injections.”
BackgroundYadav, V. K., Oury, F., Suda, N., Liu, Z.-W., Gao, X.-B., Confavreux, C., Klemenhagen, K. C., Tanaka, K. F., Gingrich, J. A., Guo, X. E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.051 · Cited by 661
Prabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641
Endocrine Regulation of Male Fertility by the Skeleton
Oury, F., Sumara, G., Sumara, O., Ferron, M., Chang, H., Smith, C. E., Hermo, L., Suarez, S., Roth, B. L., Ducy, P., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.004 · Cited by 628
Leptin in Human Physiology and Pathophysiology
Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S.-Y., Hamnvik, O.-P. R., & Koniaris, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2011 · Cited by 593 · cited 1×
“Therefore, it is difficult to establish a direct effect of leptin on human bone (228, 264).”
BackgroundLeptin is a potent stimulator of bone growth in ob/ob mice
Steppan, C. M., Crawford, D. T., Chidsey-Frink, K. L., Ke, H., & Swick, A. G. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00152-x · Cited by 512
Chen, L.-Q., Cheung, L. S., Feng, L., Tanner, W., & Frommer, W. B. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033904 · Cited by 507 · cited 1×
“The transport of glucose and other sugars across the plasma membrane of mammalian cells is facilitated by carrier proteins, which are members of the large family of uniportersymporter-antiporter proteins (52, 299).”
BackgroundAMPK: positive and negative regulation, and its role in whole-body energy homeostasis
Hardie, D. G. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.09.004 · Cited by 485 · cited 1×
“The heterotrimeric protein AMPK functions as a molecular sensor that adjusts ATP production in response to changes in cellular stress and energy status (134, 135).”
BackgroundMaternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions
Oury, F., Khrimian, L., Denny, C. A., Gardin, A., Chamouni, A., Goeden, N., Huang, Y.-Y., Lee, H., Srinivas, P., Gao, X.-B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.042 · Cited by 484 · cited 1×
“However, it remains possible that another undiscovered osteocalcin receptor exists because the effect of osteocalcin deficiency on neurotransmitters and behavior is not recapitulated in Gprc6a-null mice (258).”
BackgroundLeptin directly regulates bone cell function in vitro and reduces bone fragility in vivo
Cornish, J., Callon, K., Bava, U., Lin, C., Naot, D., Hill, B., Grey, A., Broom, N., Myers, D., Nicholson, G., et al. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750405 · Cited by 472 · cited 1×
“Most studies in osteoblast cell lines show that leptin increases osteoblast proliferation and augments phenotypic markers of the differentiated osteoblast phenotype, including alkaline phosphatase activity, collagen synthesis, and matrix mineralization (63, 89, 119, 132, 203, 287).”
BackgroundWei, W., Dutchak, P. A., Wang, X., Ding, X., Wang, X., Bookout, A. L., Goetz, R., Mohammadi, M., Gerard, R. D., Dechow, P. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200797109 · Cited by 426 · cited 1×
“Initial studies suggested that FGF21 regulates bone mass and longitudinal bone growth (48, 349, 353, 359) as Fgf21 / mice were reported to have a high bone mass phenotype, whereas transgenic overexpression leads to a reduction in trabecular bone volume (353).”
BackgroundFerron, M., McKee, M. D., Levine, R. L., Ducy, P., & Karsenty, G. (2012) · Bone · doi:10.1016/j.bone.2011.04.017 · Cited by 414 · cited 1×
“Ferron and colleagues (98, 100) continued the Karsenty laboratory’s analysis of the metabolic functions of osteocalcin by assessing its potential therapeutic use when delivered via osmotic mini-pumps or daily injections.”
BackgroundHauge, E. M., Qvesel, D., Eriksen, E. F., Mosekilde, L., & Melsen, F. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.9.1575 · Cited by 397
Esen, E., Chen, J., Karner, C. M., Okunade, A. L., Patterson, B. W., & Long, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.017 · Cited by 367
Amrein, K., Amrein, S., Drexler, C., Dimai, H. P., Dobnig, H., Pfeifer, K., Tomaschitz, A., Pieber, T. R., & Fahrleitner-Pammer, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2152 · Cited by 277
Hamrick, M. W., Della-Fera, M. A., Choi, Y.-H., Pennington, C., Hartzell, D., & Baile, C. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050103 · Cited by 268 · cited 1×
“Subcutaneous delivery of leptin corrected the skeletal phenotype (130) (though this could be acting centrally because of leptin’s ability to cross the blood-brain barrier), while also reducing the bone loss that follows ovariectomy (40).”
BackgroundPhysiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models
Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C., Flamez, D., Mu, J., Wojtaszewski, J. F. P., Schuit, F. C., Birnbaum, M., Richter, E., et al. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310216 · Cited by 241
Regulation of energy metabolism by the skeleton: osteocalcin and beyond
Ferron, M., & Lacombe, J. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.022 · Cited by 211 · cited 1×
“More than 100 published manuscripts have assessed relationships between osteocalcin levels and serum biomarkers of glucose metabolism in children and adults who are obese or have diabetes [see the article by Ferron and Lacombe (99) for a partial list].”
BackgroundMa, X., Meng, J., Jia, M., Bi, L., Zhou, Y., Wang, Y., Hu, J., He, G., & Luo, X. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1898 · Cited by 200 · cited 1×
“Furthermore, treatment of ovariectomized rats with the GLP-1 agonist exendin-4 resulted in reduced bone loss in association with a decreased urinary deoxypyridinoline (DPD)-to-creatinine ratio and serum COOH-terminal cross-linked telopeptides of type I collagen (CTX-I) and increase in serum alkaline phosphatase (ALP),…”
BackgroundReciprocal regulation of bone and energy metabolism
Lee, N. K., & Karsenty, G. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.02.006 · Cited by 190 · cited 1×
“Karsenty and colleagues reasoned that if the adipocyte hormones leptin and adiponectin influence bone mass, bone should release a hormone that closes these endocrine loops (59, 201).”
Carrasco, F., Ruz, M., Rojas, P., Csendes, A., Rebolledo, A., Codoceo, J., Inostroza, J., Basfi-fer, K., Papapietro, K., Rojas, J., et al. (2009) · Obesity Surgery · doi:10.1007/s11695-008-9638-0 · Cited by 169
Wang, X., Wei, W., Krzeszinski, J. Y., Wang, Y., & Wan, Y. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.010 · Cited by 165
Baldock, P. A., Lee, N. J., Driessler, F., Lin, S., Allison, S., Stehrer, B., Lin, E.-J. D., Zhang, L., Enriquez, R. F., Wong, I. P. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008415 · Cited by 164 · cited 1×
“sites of action as recapitulation of NPY expression in the hypothalamus was able to only partially rescue the phenotype of the null mouse (16).”
BackgroundBioenergetics During Calvarial Osteoblast Differentiation Reflect Strain Differences in Bone Mass
Guntur, A. R., Le, P. T., Farber, C. R., & Rosen, C. J. (2014) · Endocrinology · doi:10.1210/en.2013-1974 · Cited by 163 · cited 1×
“(124) used the Seahorse analyzer (Agilent Technologies, Santa Clara, CA) to estimate oxygen consumption rates and extracellular acidification in primary osteoblast cultures derived from C3H and BL6 mice, which exhibit BONE CELL METABOLISM”
MethodTransgenic rescue of insulin receptor–deficient mice
Okamoto, H., Nakae, J., Kitamura, T., Park, B.-C., Dragatsis, I., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421645 · Cited by 151 · cited 1×
“(154) examined skeletal architecture in mice globally deficient in IR but rescued from ketoacidosis by targeted reexpression of the IR in the pancreas, liver, and brain (tTr-IR knockout mice) (255).”
BackgroundWnt signaling in bone and muscle
Rudnicki, M. A., & Williams, B. O. (2015) · Bone · doi:10.1016/j.bone.2015.02.009 · Cited by 132
Kunutsor, S. K., Apekey, T. A., & Laukkanen, J. A. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0058-x · Cited by 107 · cited 1×
“Although these studies are largely crosssectional and as a result observational in nature, our analysis of the individual studies, as well as the results from three meta-analyses on subgroups from these studies (193, 210, 211), suggest the emergence of several common findings.”
ResultZhou, J., Ye, S., Fujiwara, T., Manolagas, S. C., & Zhao, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478750 · Cited by 88 · cited 1×
“Together, these and other data (19, 376) suggest that ROS-producing stimuli promote osteoclast activity, which intriguingly is the direct opposite of the effect of ROS on osteoblasts (9, 11).”
BackgroundGlucose Transporter-4 Facilitates Insulin-Stimulated Glucose Uptake in Osteoblasts
Li, Z., Frey, J. L., Wong, G. W., Faugere, M.-C., Wolfgang, M. J., Kim, J. K., Riddle, R. C., & Clemens, T. L. (2016) · Endocrinology · doi:10.1210/en.2016-1583 · Cited by 86 · cited 2×
“Moreover, mice deficient for Glut4 specifically in osteoblasts and osteocytes developed an increase in adipose tissue in association with hyperinsulinemia, -cell islet hypertrophy, and reduced insulin sensitivity (208).”
BackgroundSelf-citationZhou, B., Li, H., Xu, L., Zang, W., Wu, S., & Sun, H. (2013) · Endocrinology · doi:10.1210/en.2012-2144 · Cited by 86
Kim, Y., Nam, J. S., Yeo, D., Kim, K. R., Suh, S., & Ahn, C. W. (2015) · Clinical Endocrinology · doi:10.1111/cen.12601 · Cited by 82 · cited 1×
“Second, improvements in insulin sensitivity induced by weight loss (6, 286) or exercise (184, 223) are associated with increased circulating osteocalcin.”
BackgroundHill, H., Grams, J., Walton, R., Liu, J., Moellering, D., & Garvey, W. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1368709 · Cited by 80 · cited 1×
“Studies from other groups have since confirmed these results using in vitro models (144, 257, 374), while also showing that oral administration of osteocalcin produces similar metabolic benefits in vivo (239, 240).”
ResultChan, J. L., Mietus, J. E., Raciti, P. M., Goldberger, A. L., & Mantzoros, C. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02684.x · Cited by 68 · cited 2×
“However, it is clear that the proposed site-dependent effects of leptin in the axial and appendicular skeleton of ob/ob mice (131) are not apparent in humans (167, 293), and leptin does not appear to regulate short-term fastinginduced autonomic changes or alter catecholamine levels in humans (47).”
BackgroundFGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists
Li, X., Stanislaus, S., Asuncion, F., Niu, Q.-T., Chinookoswong, N., Villasenor, K., Wang, J., Wong, P., Boyce, R., Dwyer, D., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2936 · Cited by 61 · cited 1×
“However, the results from a recent study (207) reporting no skeletal changes in mice lacking FGF21, and no alterations in bone after administration of recombinant FGF21 has called into question the significance of FGF21 in skeletal metabolism.”
ResultBrown, P. M., Hutchison, J. D., & Crockett, J. C. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9537-6 · Cited by 37 · cited 1×
“(38) demonstrated that glutamine supplementation improved osteoblast viability in a low-glucose environment and that glutamine availability was necessary for matrix mineralization.”
Background
Cited by
Ho-Shui-Ling, A., Bolander, J., Rustom, L. E., Johnson, A. W., Luyten, F. P., & Picart, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.017 · Cited by 961
Zhou, T., Yang, Y., Chen, Q., & Xie, L. (2019) · Stem Cells International · doi:10.1155/2019/8928934 · Cited by 73
Biphasic regulation of glutamine consumption by WNT during osteoblast differentiation
Shen, L., Sharma, D., Yu, Y., Long, F., & Karner, C. (2020) · Journal of Cell Science · doi:10.1242/jcs.251645 · Cited by 61
Tower, R. J., Busse, E., Jaramillo, J., Lacey, M., Hoffseth, K., Guntur, A. R., Simkin, J., & Sammarco, M. C. (2022) · eLife · doi:10.7554/elife.71542 · Cited by 43
Zhang, X., Tian, L., Majumdar, A., & Scheller, E. L. (2024) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2024.tb00300.x · Cited by 18
Metadata
- Authors
- Riddle, R. C., & Clemens, T. L.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2017-04
- Volume
- 97
- Issue
- 2
- Pages
- 667-698
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2588575372
- Cited by
- 101
- References
- 61
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.